Serum-Free Cell Culture Can Cost Less: 

Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost


InVitria and Lampire to Host Webinar on Monoclonal Antibody Production

Fort Collins, CO April 27, 2011 – InVitria and Lampire Biological are hosting a webinar to share a strategy to eliminate contaminating IgG’s from serum while reducing monoclonal antibody (MAb) production costs. The webinar will be broadcast live at 11:30am MDT on May 10, 2011 and will be archived on InVitria’s website for future viewing.

MAbs are a valuable asset in the development of future medicines, from use as basic research tools to large-scale biotherapeutics.  Given the versatility and convenience offered by using hybridomas to produce MAbs, scientists continue to expand upon the vast potential these proteins represent.  However, limitations in hybridoma productivity and costly purification processes associated with contaminating materials, such as IgG from bovine serum used in hybridoma culture medium, can significantly increase MAb costs.

During this webinar, the challenges facing non-therapeutic MAb production will be discussed. Annette Flood, Monoclonal Department Manager, Lampire Biological Laboratory will present a case study to show Lampire’s success in reducing costs and improving performance in serum-free hybridoma cell culture conditions and Mab production.

“The development of technologies to improve the consistency and purification of monoclonal antibody production is key to reducing manufacturing costs,” said Brittany Medbery, InVitria. “In this webinar we will share the successful implementation of this technology.”

To sign up for the webinar “Serum-Free Cell Culture Can Cost Less:  Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost”, register here.


About InVitria
(www.InVitria.com)

InVitria develops, manufactures, and markets a portfolio of products used in cell culture, diagnostics, and bioproduction. InVitria’s products address customer needs for defined, animal component free cell culture supplements in stem cell technology, regenerative medicine, biomanufacturing, diagnostics, biopharmaceutical formulation, cell-based vaccines, and general life science research.

To obtain more information about InVitria’s product solutions, e-mail This e-mail address is being protected from spambots. You need JavaScript enabled to view it This e-mail address is being protected from spambots. You need JavaScript enabled to view it , visit us online at www.InVitria.com , or call toll-free 1-800-916-8311.


About Lampire Biological Laboratory
(www.Lampire.com)

Lampire Biological Laboratory is a privately owned company founded in Pennsylvania over 30 years ago specializing in polyclonal and monoclonal antibody development, cell culture services, a wide variety of human and animal blood-derived products, purified IgGs, plus a comprehensive line of animal tissues and organs. Lampire is committed to consistently providing the highest quality, most reliable products and services possible in conformity with our customers’ requirements, specifications, and standards.

For additional information, contact Lampire at 215-795-2838 or visit their website www.Lampire.com.

###

 
  • Blog: The Cell Culture Dish

    Cell Culture Media supplement Blog Strategies for Improving Viral Yield in Vaccine Manufacturing

    A recent article in Pharma Times titled "US biopharma: nearly 300 vaccines in R&D," points out that there are currently 300 vaccines either in clinical studies or under review by the Food and Drug Administration (FDA). While not all vaccines are cell culture derived vaccines, it does indicate that a large number of cell culture based viral vaccines are in the pipeline and that perhaps viral vaccine manufacturing should be examined. One area under consideration is how to improve viral yield so that vaccines can be made at lower cost ... Read More

  • Latest News

    Invitria Cell Culture Media News InVitria Attends the 13th Bi-Annual Cell Culture Engineering Conference

    March 29, 2012 - InVitria is attending the 13th Bi-Annual Cell Culture Engineering Conference in Scottsdale, Arizona April 22nd through the 27th. This event is an invitation only conference that includes approximately 350 of the world's top academic and industry cell culture scientists. Topics at the conference range from fundamental science to the engineering challenges of cell culture process development.... read more